EGFR and glioblastoma: Moreover, in an independent MSKCC GBM sample cohort, 37% of samples (n = 225) with high level immunopositivity for phospho-EGFR also showed strong PDGFRA protein expression (Supplementary Table S1 and Supplementary Fig. 1a).